WANY
RNXT icon

Wealthspire Advisors (New York)’s RenovoRx RNXT Stock Holding History

Wealthspire Advisors (New York)’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$255K Hold
252,525
– – ﹤0.01% 777
2025
Q4 		$212K Buy
+252,525
New +$253K ﹤0.01% 950

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $4.12B AUM

Wealthspire Advisors (New York)'s RNXT Position: Q1 2026 in Review

Wealthspire Advisors (New York) held its RenovoRx (RNXT) position steady in Q1 2026 at 252,525 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Wealthspire Advisors (New York) first reported a position in RNXT in Q4 2025 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.

  • Wealthspire Advisors (New York) held 252,525 shares of RenovoRx worth $255K as of Q1 2026.
  • Wealthspire Advisors (New York) left its RenovoRx share count unchanged in Q1 2026.
  • RenovoRx made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #777 holding.
  • Wealthspire Advisors (New York) first reported a position in RenovoRx in Q4 2025 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.